ALFRED D KINGSLEY
CIK 1229339 · Chairman · last filed 2023-07-03
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$7.42M
Companies
5
Total Filings
59
Lifetime Open-Market Net
-$3.23M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LCTX | Chairman | 5,845,596 | $1.27 | $7.42M | $0 | 5 | 2023-07-03 |
| Insight Molecular Diagnostics Inc. (OCX) Delisted | Director | 507,878 | $3.20 | $1.63M | $7.9K | 15 | 2023-06-27 |
| Lineage Cell Therapeutics, Inc. (BTX.WS) Delisted | See Remarks | 5,846,906 | — | — | -$3.27M | 33 | 2018-07-03 |
| Asterias Biotherapeutics, Inc. (AST.WS) Delisted | Director | 9,000 | — | — | $11.7K | 1 | 2016-06-10 |
| Asterias Biotherapeutics, Inc. (AST) Delisted | Director | 5,000 | — | — | $21.6K | 3 | 2016-03-01 |
Recent Filings · Page 5 of 6
59 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2012-12-18 | Lineage Cell Therapeutics, Inc. (BTX.WS) Delisted | Other (J) | −57,511 | -$249.4K | EDGAR |
| 2012-11-19 | Lineage Cell Therapeutics, Inc. (BTX.WS) Delisted | Sell (S) | −344,828 | -$1.00M | EDGAR |
| 2012-07-31 | Lineage Cell Therapeutics, Inc. (BTX.WS) Delisted | Other (J) | −140,000 | -$667.3K | EDGAR |
| 2012-07-03 | Lineage Cell Therapeutics, Inc. (BTX.WS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2011-07-06 | Lineage Cell Therapeutics, Inc. (BTX.WS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2010-11-03 | Lineage Cell Therapeutics, Inc. (BTX.WS) Delisted | Exer (X) | +1,037,058 | $2.07M | EDGAR |
| 2010-10-26 | Lineage Cell Therapeutics, Inc. (BTX.WS) Delisted | Buy (P) | — | $0 | EDGAR |
| 2010-10-25 | Lineage Cell Therapeutics, Inc. (BTX.WS) Delisted | Exer (X) | +447,004 | $894.0K | EDGAR |
| 2010-08-20 | Lineage Cell Therapeutics, Inc. (BTX.WS) Delisted | Mixed | +982,900 | $1.82M | EDGAR |
| 2010-08-12 | Lineage Cell Therapeutics, Inc. (BTX.WS) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.